How to Get a GLP-1 Prescription Online in 2026: Step-by-Step Guide

The 4-Step Process to Getting GLP-1 Online

The process of getting a GLP-1 prescription online follows the same medical standards as an in-person visit. The difference is in the delivery method. Instead of driving to a clinic, you complete each step from your computer or phone. Let us walk through the entire process in detail so you know exactly what to expect.

Step 1 - Complete Your Health Assessment

Every legitimate telehealth GLP-1 provider starts with a health assessment. This is not a formality. It is the foundation of your medical evaluation, and the information you provide directly shapes the care you receive.

The health assessment is an online questionnaire that collects the medical information your provider needs to evaluate whether you are a good candidate for GLP-1 medication. Think of it as the paperwork you would fill out in a doctor’s waiting room, except you can complete it from your couch.

What the assessment covers:

A thorough health assessment asks about several categories of information. The first is your basic biometrics. You will enter your height, weight, age, and biological sex. The system typically calculates your BMI automatically. This is the starting point for eligibility. FDA-approved GLP-1 medications for weight management are indicated for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition.

The second category is your complete medical history. Expect questions about any current or past medical conditions. This includes cardiovascular disease, type 2 diabetes, high blood pressure, high cholesterol, thyroid conditions, pancreatitis, kidney disease, liver disease, gallbladder problems, and mental health conditions. Your provider needs this information to identify any contraindications or conditions that require special monitoring.

Certain conditions are absolute contraindications for GLP-1 medications. The most important is a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). If you have a history of these conditions, GLP-1 medications are not appropriate, and a responsible provider will identify this during the assessment.

The third category is your current medication list. You will be asked to list every prescription medication, over-the-counter drug, and supplement you take. This is critical because GLP-1 medications can interact with other drugs. For example, GLP-1 agonists slow gastric emptying, which can affect how quickly your body absorbs oral medications. This is especially important for medications with narrow therapeutic windows, such as warfarin, levothyroxine, and certain oral contraceptives.

The fourth category covers your weight loss history. Your provider wants to understand what you have already tried. Have you attempted diet and exercise programs? Have you used other weight loss medications? Have you had bariatric surgery? This context helps your provider understand your process and determine whether GLP-1 medication is the right next step.

The fifth category addresses your health goals. Are you primarily interested in weight loss, blood sugar management, or both? Do you have a target weight in mind? Understanding your goals helps your provider tailor the treatment plan.

How long it takes:

Most health assessments take 10 to 15 minutes to complete. Some platforms allow you to save your progress and come back to it later. If you have your medication list and medical history handy, you can move through it quickly. If you need to look up information, it may take a bit longer. There is no rush. Take the time to be thorough and accurate, because this information shapes your entire treatment.

Why accuracy matters:

It can be tempting to minimize or omit information on a health assessment, especially if you are eager to get started on medication. Do not do this. Your provider relies on this information to keep you safe. Omitting a medication you take or downplaying a health condition could lead to a prescription that interacts with another drug, a missed contraindication, or inadequate monitoring of a condition that requires attention.

Be honest and complete. If you are unsure whether something is relevant, include it. Your provider would rather have too much information than too little.

Step 2 - Telehealth Consultation with a Licensed Provider

After you submit your health assessment, a licensed provider reviews your information and conducts a consultation. This is the core of the medical evaluation, and it is where the prescribing decision is made.

Types of telehealth consultations:

Telehealth consultations come in two main formats. The first is a synchronous video consultation. This is a live, face-to-face conversation with your provider through a video call. You can ask questions in real time, and the provider can observe you and respond to your concerns immediately. Video consultations typically last 15 to 30 minutes.

The second format is an asynchronous consultation. In this model, your provider reviews your health assessment and communicates with you through a secure messaging portal. You may exchange several messages over the course of 24 to 48 hours. The provider asks follow-up questions, you respond, and the conversation continues until the provider has enough information to make a clinical decision.

Both formats are legally valid in most states, though some states require a synchronous (live) consultation for certain medications or for initial prescriptions. Your telehealth platform will guide you to the appropriate format based on your location.

What the provider evaluates:

Your provider is looking at several factors during the consultation. The first is clinical eligibility. Do you meet the BMI and medical criteria for a GLP-1 prescription? Are there any contraindications in your medical history? Are your current medications compatible with GLP-1 therapy?

The second factor is medical appropriateness. Even if you meet the eligibility criteria, your provider considers whether GLP-1 medication is the best option for your specific situation. For some patients, other approaches may be more appropriate first, or additional evaluation may be needed before starting medication.

The third factor is safety planning. If the provider determines that GLP-1 medication is appropriate, they consider which medication and starting dose is safest for you, what monitoring is needed, and what follow-up schedule is appropriate.

Questions your provider may ask:

Beyond what you included in your health assessment, your provider may ask about your eating patterns and relationship with food, your exercise habits and physical activity level, your sleep quality and duration, your stress levels and mental health, whether you have any upcoming surgeries or procedures (GLP-1 medications may need to be paused before anesthesia), and whether you are pregnant, breastfeeding, or planning to become pregnant (GLP-1 medications are contraindicated during pregnancy).

The prescribing decision:

At the end of the consultation, your provider makes one of three decisions. The first is to approve your prescription and move forward with a treatment plan. The second is to request additional information, such as lab work, before making a final decision. The third is to determine that GLP-1 medication is not appropriate for you at this time and recommend alternative approaches.

If you are approved, your provider will explain the recommended medication, the starting dose, the dose escalation schedule, potential side effects to watch for, and when your first follow-up appointment will be.

Step 3 - Prescription and Medication Selection

Once your provider approves your treatment, they write a prescription for the specific GLP-1 medication they recommend. This is where the details of your treatment plan take shape.

How your provider chooses your medication:

Several factors influence which medication your provider prescribes. Your medical profile is the primary consideration. If you have type 2 diabetes in addition to obesity, your provider may choose a medication with strong glucose-lowering data. If weight loss is the primary goal, they may prioritize a medication with the strongest weight loss data.

Insurance coverage is another factor. If you have insurance that covers brand-name GLP-1 medications, your provider may prescribe Wegovy (semaglutide 2.4 mg) or Zepbound (tirzepatide) since these are FDA-approved for weight management. If you are paying out of pocket, your provider may recommend a compounded formulation that offers the same active ingredient at a lower cost.

Availability also plays a role. GLP-1 medications have experienced supply constraints since their surge in popularity. Your provider considers which medications are currently in stock and available through the pharmacy network.

Your personal preferences matter as well. Some patients prefer a weekly injection while others are interested in emerging oral formulations. Some patients have a preference for brand-name medications while others are comfortable with compounded versions. Your provider takes these preferences into account alongside the clinical factors.

Starting dose and escalation:

GLP-1 medications are always started at a low dose and gradually increased over several weeks or months. This slow escalation is critical for managing side effects, particularly the gastrointestinal symptoms (nausea, vomiting, diarrhea) that are common when starting these medications.

For semaglutide, the typical starting dose is 0.25 mg weekly, increasing to 0.5 mg after four weeks, then to 1 mg, 1.7 mg, and eventually the target dose of 2.4 mg. Each dose increase happens at four-week intervals, so reaching the full dose takes about 16 to 20 weeks.

For tirzepatide, the starting dose is typically 2.5 mg weekly, increasing to 5 mg after four weeks, then 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg. The escalation schedule is similar, with increases every four weeks.

Your provider may adjust this schedule based on how you respond to the medication and any side effects you experience.

The prescription itself:

Your provider sends the prescription electronically to a pharmacy. If you are using a brand-name medication, the prescription goes to a retail or specialty pharmacy. If you are using a compounded formulation, it goes to a licensed compounding pharmacy. In either case, the prescription includes the medication name, dose, quantity, refill information, and any special instructions.

Step 4 - Pharmacy Fulfillment and Delivery

The final step is getting your medication from the pharmacy to your door. This process varies depending on whether you are receiving a brand-name or compounded medication.

Brand-name fulfillment:

If your provider prescribes a brand-name medication like Wegovy or Zepbound, the prescription is sent to a specialty pharmacy. The pharmacy verifies your prescription, checks your insurance if applicable, processes any prior authorization requirements, and then fills and ships the medication.

Brand-name GLP-1 medications come in pre-filled injection pens. The pens are shipped in insulated packaging with cold packs to maintain the required temperature range. Shipping typically takes 3 to 5 business days, and you may be able to select expedited shipping for an additional fee.

Compounded fulfillment:

If your provider prescribes a compounded formulation, the prescription is sent to a licensed compounding pharmacy. Compounding pharmacies prepare the medication specifically for your prescription. The active ingredient (semaglutide or tirzepatide) is the same, but the formulation may differ slightly from the brand-name version.

Compounded medications are typically shipped in vials rather than pre-filled pens. You will receive the vial along with syringes and needles for injection. Like brand-name medications, compounded formulations require cold-chain shipping and should be refrigerated upon arrival.

What to expect when your package arrives:

When your medication arrives, inspect the package immediately. Check that the outer packaging is intact and the cold packs inside are still cool. Look at the medication itself to ensure it is clear and colorless (or the expected color for your specific formulation). Check the expiration date on the vial or pen. If anything looks wrong - if the cold packs are fully thawed and warm, if the medication is cloudy or discolored, or if the packaging is damaged - contact the pharmacy before using the medication.

Place the medication in your refrigerator right away. The recommended storage temperature for most GLP-1 medications is 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius). Do not freeze the medication. If it has been frozen, do not use it.

Timeline summary:

From the moment you start your health assessment to the moment your medication arrives, the entire process typically takes 7 to 14 days. The health assessment and consultation can happen within 24 to 48 hours. Pharmacy processing takes 1 to 3 days. Shipping takes 3 to 5 business days. Some platforms offer faster turnaround, but this timeline is typical for most patients.

Telehealth vs In-Person - Complete Comparison

One of the biggest decisions you will make when pursuing GLP-1 treatment is whether to use a telehealth platform or see a provider in person. Both approaches involve real medical oversight and can lead to the same prescription. The difference is in the experience, the timeline, and the logistics. Let us compare them thoroughly so you can make an informed choice.

Benefits of Telehealth for GLP-1 Prescriptions

Convenience and time savings:

The most obvious advantage of telehealth is convenience. You do not need to take time off work, arrange childcare, drive to a clinic, or sit in a waiting room. You complete the health assessment when it fits your schedule - whether that is during a lunch break, after the kids are in bed, or on a weekend morning. For busy professionals, parents, or anyone with a demanding schedule, this flexibility is significant.

The time savings extend beyond the appointment itself. Consider the total time investment of an in-person visit. You have the scheduling delay (often 2 to 4 weeks for a new patient appointment), the travel time, the waiting room, the appointment itself, the trip to the pharmacy, and any follow-up visits. With telehealth, the assessment-to-prescription timeline is often 24 to 48 hours, and follow-up appointments happen through the same platform without any additional travel.

Cost efficiency:

Telehealth consultations for GLP-1 medications are often more affordable than in-person visits. Many telehealth platforms bundle the consultation fee into the medication cost, so you pay one price that includes the medical evaluation, the prescription, and the medication itself. In-person office visits typically cost $150 to $350 before insurance, and that does not include the medication cost.

There are also indirect cost savings. You are not paying for gas, parking, or time away from work. Over the course of a year of treatment with monthly follow-ups, these savings add up meaningfully.

Access to specialized providers:

Not every primary care physician has extensive experience with GLP-1 medications. Depending on where you live, finding a provider who specializes in obesity medicine or has significant experience prescribing these medications may be difficult. Telehealth removes the geographic barrier. You can consult with a provider who specializes in GLP-1 treatment regardless of whether they practice in your city or across the country (as long as they are licensed in your state).

This specialization matters. Providers who focus on GLP-1 medications are often more up-to-date on the latest research, more experienced in managing side effects, and more efficient in the prescribing process. They have seen hundreds or thousands of patients on these medications and can draw on that experience to guide your treatment.

Privacy:

For many people, seeking treatment for obesity or weight management carries stigma. Walking into a weight loss clinic, sitting in a waiting room, and discussing your weight with a receptionist can feel uncomfortable. Telehealth eliminates these interactions. Your consultation happens privately, on your own device, in your own space. No one else needs to know.

This privacy factor is not trivial. Research has consistently shown that stigma and embarrassment are significant barriers to seeking obesity treatment. Telehealth lowers these barriers and helps more people access care they might otherwise avoid.

Benefits of In-Person Care for GLP-1 Prescriptions

Physical examination:

A telehealth visit cannot fully replicate a hands-on physical exam. If you have a complex medical history, multiple comorbidities, or conditions that require physical assessment, an in-person visit may provide more thorough evaluation. Your provider can listen to your heart and lungs, palpate your thyroid, check for signs of fluid retention, and perform other physical exam components that are not possible through a screen.

That said, for most straightforward GLP-1 prescribing scenarios, the information gathered through a health assessment and telehealth consultation is sufficient. Physical exam findings rarely change the prescribing decision for GLP-1 medications in otherwise healthy patients who meet the standard eligibility criteria.

In-office lab work:

Some patients prefer to have their blood drawn at the same visit where they see their provider. An in-person office can often draw labs on-site or send you directly to an adjacent lab facility. This can feel more convenient than ordering an at-home kit or scheduling a separate lab visit, particularly if you are already familiar with the in-office process.

Ongoing provider relationship:

Some patients value the in-person relationship they build with their provider over time. Seeing the same physician face-to-face at every visit can create a sense of continuity and trust that some patients find harder to establish through a screen. If you already have a primary care physician you trust and they are experienced with GLP-1 medications, continuing your care in person may make the most sense.

When In-Person Is Required

There are specific situations where an in-person visit is necessary or strongly recommended for GLP-1 treatment.

Complex medical histories: If you have multiple serious medical conditions, a history of bariatric surgery, active cancer treatment, or other complex health situations, an in-person evaluation may be necessary before starting GLP-1 medication. Some telehealth providers may refer you to an in-person specialist in these cases.

State regulations: While most states permit telehealth prescribing for GLP-1 medications, some states have specific requirements that may necessitate an in-person visit for the initial prescription. Your telehealth platform will inform you if this applies to your state.

Insurance requirements: Some insurance plans require an in-person evaluation before authorizing coverage for GLP-1 medications. If you plan to use insurance for a brand-name medication, check your plan’s requirements before starting the telehealth process.

Severe side effects or complications: If you experience severe side effects while on GLP-1 medication - such as persistent vomiting, signs of pancreatitis, or allergic reactions - you should seek in-person medical care immediately, regardless of whether your prescribing provider is a telehealth platform.

Hybrid Approaches

You do not have to choose exclusively between telehealth and in-person care. Many patients use a hybrid approach that combines the benefits of both.

One common hybrid model is to get your initial prescription through a telehealth platform for speed and convenience, then coordinate with your primary care physician for ongoing monitoring. Your PCP can order lab work, perform periodic physical exams, and integrate your GLP-1 treatment into your overall healthcare plan.

Another hybrid approach is to see a provider in person for the initial evaluation and then switch to telehealth for follow-up visits. This gives you the benefit of a thorough in-person assessment up front while avoiding the need to travel to the office every month for routine check-ins.

Some telehealth platforms actively encourage this coordination. They can send visit summaries and prescribing information to your primary care physician, so your entire healthcare team is on the same page. This collaborative approach can provide the best of both worlds: specialized GLP-1 expertise from your telehealth provider and comprehensive primary care from your local physician.

Whatever approach you choose, the most important factor is that you receive consistent, ongoing medical supervision throughout your treatment. GLP-1 medications are generally safe and well-tolerated, but they are still prescription medications that require appropriate monitoring.

What Happens During Your Telehealth Consultation

Your telehealth consultation is the most important step in the online prescription process. This is where a licensed provider reviews your medical information, evaluates your eligibility, and makes the clinical decision about whether to prescribe GLP-1 medication. Understanding what happens during this consultation helps you prepare and get the most out of the experience.

Medical History Review

The consultation begins with your provider reviewing the health assessment you submitted. Even though you already entered this information, expect your provider to ask follow-up questions. They are looking for nuances and details that a questionnaire cannot capture.

Your provider will want to understand the full context of your medical history. This means going beyond a list of diagnoses. They will ask about when conditions were diagnosed, how they are currently being managed, whether they are well-controlled, and whether they have changed recently. For example, if you listed high blood pressure on your assessment, your provider may ask what your typical readings are, what medication you take for it, when it was last adjusted, and whether you monitor it at home.

They will pay particular attention to conditions that are directly relevant to GLP-1 prescribing. These include type 2 diabetes and prediabetes (because GLP-1 medications affect blood sugar), thyroid conditions (because of the boxed warning about medullary thyroid carcinoma), a history of pancreatitis (because GLP-1 medications carry a small risk of pancreatitis), gastroparesis or other gastric motility disorders (because GLP-1 medications slow gastric emptying), and any history of eating disorders (because the appetite-suppressing effects of GLP-1 medications require careful management in patients with disordered eating).

Your provider will also ask about your surgical history, particularly any gastrointestinal surgeries, bariatric procedures, or upcoming planned surgeries. GLP-1 medications may need to be paused before surgeries involving anesthesia due to the risk of aspiration from delayed gastric emptying.

Current Medications Discussion

Your provider will review every medication you take, including prescription drugs, over-the-counter medications, and supplements. This is not a formality. Drug interactions with GLP-1 medications are real and clinically important.

The primary interaction concern is with oral medications that depend on consistent absorption. Because GLP-1 agonists slow gastric emptying, they can alter how quickly other oral medications are absorbed. This is most relevant for medications with narrow therapeutic windows, where small changes in absorption can affect how the drug works.

Key medications your provider will flag include insulin and sulfonylureas (because combining them with GLP-1 medications increases the risk of hypoglycemia and doses may need adjustment), warfarin and other anticoagulants (because changes in absorption could affect clotting times), levothyroxine (because absorption may be delayed, though clinical significance is debated), oral contraceptives (because absorption timing may shift, though most providers consider this a low risk with modern formulations), and certain antibiotics and antiretroviral medications.

If you take insulin for type 2 diabetes, your provider will pay close attention to your current regimen and may recommend insulin dose adjustments when starting a GLP-1 medication to prevent hypoglycemia. This coordination is one reason why having a knowledgeable provider is so important.

Supplements also matter. Your provider may ask about herbal supplements, vitamins, and other products you take regularly. While most supplements do not interact significantly with GLP-1 medications, some herbal products can affect blood sugar or blood pressure, and your provider needs the full picture.

BMI and Eligibility Evaluation

Your provider will confirm your BMI eligibility during the consultation. The standard criteria for GLP-1 prescribing for weight management are a BMI of 30 or greater (obesity), or a BMI of 27 or greater (overweight) with at least one weight-related comorbidity.

Weight-related comorbidities that qualify include type 2 diabetes, hypertension (high blood pressure), dyslipidemia (high cholesterol or triglycerides), obstructive sleep apnea, cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), and osteoarthritis of weight-bearing joints.

Your provider may also consider other clinical factors beyond the strict BMI cutoffs. For example, patients with a BMI just below 27 but with significant metabolic dysfunction may still benefit from GLP-1 treatment, though prescribing in these cases is considered off-label and requires additional clinical justification.

BMI is calculated by dividing your weight in kilograms by the square of your height in meters. For reference, a person who is 5 feet 6 inches tall and weighs 186 pounds has a BMI of approximately 30. A person who is 5 feet 10 inches tall and weighs 195 pounds has a BMI of approximately 28. If you are unsure of your BMI, any online BMI calculator can give you an estimate, though your provider will confirm the calculation.

Treatment Plan Discussion

If your provider determines you are a good candidate for GLP-1 medication, the consultation shifts to discussing your treatment plan. This is the collaborative part of the visit where you and your provider align on the approach.

Your provider will explain the recommended medication, why they chose it for you specifically, the starting dose, the expected dose escalation schedule, the anticipated timeline for seeing results, common side effects and how to manage them, the importance of lifestyle modifications alongside medication, and the follow-up schedule.

This is also when your provider will discuss realistic expectations. GLP-1 medications produce significant weight loss in clinical trials, with average results ranging from 15 to 22 percent of body weight depending on the medication and dose. However, individual results vary widely. Some patients lose more, some less. Factors like adherence, diet, exercise, sleep, stress, and genetics all influence outcomes. A responsible provider sets realistic expectations and emphasizes that medication works best as part of a comprehensive approach that includes nutrition and physical activity.

Your provider will also discuss what happens if the medication does not work as expected. Not every patient responds to the first GLP-1 medication they try. If you do not see adequate results after reaching the target dose and giving the medication sufficient time (typically 12 to 16 weeks at the maintenance dose), your provider may recommend switching to a different GLP-1 medication, adjusting your dose, or adding other interventions.

Lab Requirements

Most providers require baseline lab work before or shortly after starting GLP-1 medication. Labs serve two purposes: they help confirm eligibility and establish a baseline for monitoring your health during treatment.

The specific labs your provider orders may vary, but a typical panel includes a comprehensive metabolic panel (CMP), hemoglobin A1C, a lipid panel, and thyroid function tests (TSH at minimum, sometimes free T4). Some providers also order a complete blood count (CBC), a urinalysis, and liver function tests if not already included in the CMP.

Your provider may accept recent lab results if you have had blood work done in the past 6 to 12 months. If not, they will order new labs. Depending on the platform, you may receive an at-home lab collection kit, a lab order for Quest Diagnostics or LabCorp, or instructions to have labs drawn through your primary care physician.

Follow-up labs are typically recommended at 3 months, 6 months, and then every 6 to 12 months during treatment. These help your provider monitor your metabolic health, check for any adverse effects, and adjust your treatment plan as needed. We will cover lab requirements in more detail in the next section.

Questions to Ask Your Provider

Your telehealth consultation is your opportunity to get answers to any questions you have. Do not hesitate to ask anything that is on your mind. Here are questions worth asking if your provider does not address them proactively:

About the medication: Why are you recommending this specific medication for me? What are the most common side effects I should expect? How should I manage nausea during the first few weeks? When should I call you about a side effect versus going to urgent care?

About the process: How often will we have follow-up appointments? How do I reach you between appointments if I have a question? What happens if I miss a dose? How long will I need to be on this medication?

About lifestyle: Do I need to follow a specific diet? What exercise is recommended? Are there foods I should avoid? How much protein should I aim for each day?

About logistics: When will my prescription be sent to the pharmacy? How long will shipping take? What should I do if my medication arrives warm? How do I store it properly?

About long-term planning: What happens when I reach my goal weight? Will I need to stay on this medication indefinitely? What are the options for stepping down the dose? How do I prevent weight regain if I stop the medication?

Write your questions down before the consultation so you do not forget them. A good provider will take the time to answer every question thoroughly.

Required Health Information and Labs

Lab work is a fundamental part of getting a GLP-1 prescription, whether online or in person. Your provider needs objective data about your metabolic health to prescribe safely and to establish a baseline for tracking your progress during treatment. Here is a complete breakdown of what is needed, why, and where to get it done.

Basic Biometrics

Before you even get to lab work, your provider needs basic biometric data. This is information you can provide yourself.

Height and weight: These are used to calculate your BMI, which is the primary eligibility criterion. Be accurate. Use a reliable scale and measure your height carefully. If you are unsure of your exact height, measure yourself against a wall or doorframe. Some providers may ask you to photograph your scale reading or confirm your weight during a video consultation.

Blood pressure: If you have a home blood pressure monitor, take a reading and include it in your health assessment. If you do not have one, note the most recent reading from a healthcare visit. High blood pressure is both a qualifying comorbidity and a condition that your provider will monitor during treatment. If you do not have a recent blood pressure reading and do not own a monitor, many pharmacies offer free blood pressure checks.

Waist circumference: Some providers ask for your waist measurement. Waist circumference is an independent predictor of metabolic risk. A waist circumference greater than 40 inches in men or 35 inches in women indicates increased metabolic risk, even in patients with a BMI below the obesity threshold. To measure accurately, wrap a tape measure around your waist at the level of your belly button, keeping it snug but not tight, and read the measurement after a normal exhale.

Blood Work Requirements

Lab work gives your provider objective data about your metabolic health. Here are the standard tests and what they tell your provider.

Comprehensive metabolic panel (CMP): This is the most important baseline test. It measures your fasting blood glucose (a snapshot of your current blood sugar), blood urea nitrogen and creatinine (kidney function markers), liver enzymes AST and ALT (liver function markers), electrolytes including sodium, potassium, calcium, and chloride, and total protein and albumin. Your provider uses this panel to ensure your kidneys and liver are functioning well enough to safely process medication, and to establish baselines for all of these values.

Hemoglobin A1C: This test measures your average blood sugar over the previous 2 to 3 months. It is the gold standard for diagnosing and monitoring diabetes. A normal A1C is below 5.7 percent. Prediabetes is 5.7 to 6.4 percent. Diabetes is 6.5 percent or above. Your provider uses this to determine whether you have diabetes or prediabetes (which may influence medication choice), establish a baseline for monitoring blood sugar improvements during treatment, and determine whether diabetes-specific GLP-1 dosing is appropriate.

Lipid panel: This measures your total cholesterol, LDL (often called "bad" cholesterol), HDL (often called "good" cholesterol), and triglycerides. Dyslipidemia is a qualifying comorbidity for GLP-1 prescribing and a significant cardiovascular risk factor. GLP-1 medications have been shown to improve lipid profiles in many patients, so having a baseline allows your provider to track these improvements.

Thyroid function (TSH): Thyroid function testing is particularly important because all GLP-1 receptor agonist medications carry a boxed warning about the risk of thyroid C-cell tumors. This risk was identified in rodent studies and has not been confirmed in humans, but it necessitates caution. Your provider uses TSH to screen for existing thyroid disease and to establish a baseline for ongoing monitoring. If your TSH is abnormal, your provider may order additional thyroid tests (free T4, free T3) before proceeding.

Medical History Documentation

Beyond lab work, your provider needs comprehensive medical history documentation. This includes a list of all current and past medical diagnoses, surgical history including dates and types of procedures, family medical history (particularly thyroid cancer, pancreatitis, and type 2 diabetes), allergy history including drug allergies and food allergies, hospitalization history, and mental health history including any history of depression, anxiety, eating disorders, or suicidal ideation.

The mental health component is worth highlighting. GLP-1 medications have been studied for potential effects on mood and mental health. While most data suggest these medications are safe for patients with mental health conditions, your provider needs to be aware of your mental health history to provide appropriate monitoring and support.

Current Medication List

Your medication list should be exhaustive. Include every prescription medication with the name, dose, and frequency. Include over-the-counter medications you take regularly, such as pain relievers, antacids, allergy medications, and sleep aids. Include all supplements, including vitamins, minerals, herbal products, and protein powders. Include any recreational substances you use, including alcohol and cannabis, as these can interact with medications and affect treatment outcomes.

Be specific about doses and frequencies. "Blood pressure medication" is not as helpful as "lisinopril 20 mg once daily." The more precise you are, the better your provider can evaluate potential interactions and adjust your treatment plan accordingly.

Where to Get Labs Done

You have several options for getting your lab work completed, each with its own advantages.

At-home lab kits: Some telehealth platforms offer at-home blood collection kits that are shipped to you. These typically use a finger-prick method to collect a small blood sample, which you then mail back to the lab in a prepaid envelope. Results are usually available within 3 to 7 business days. The advantage is maximum convenience. You do not need to leave home or schedule an appointment. The disadvantage is that finger-prick samples are sometimes insufficient for all tests, and some patients find the collection process uncomfortable.

Quest Diagnostics: Quest is one of the largest laboratory networks in the United States, with thousands of patient service centers across the country. Your provider can send a lab order to Quest electronically, and you schedule an appointment at a location near you. Blood is drawn by a phlebotomist, and results are typically available within 1 to 3 business days. Many insurance plans cover lab work at Quest.

LabCorp: LabCorp is the other major national laboratory network. The process is similar to Quest. Your provider sends a lab order, you schedule an appointment at a nearby LabCorp location, and results are returned within 1 to 3 business days. Like Quest, most insurance plans cover LabCorp tests.

Your primary care physician: If you have a primary care provider, you can ask them to order the necessary lab work. This can be convenient if you are due for routine blood work anyway. Your PCP can order the tests during a regular visit, and you can share the results with your telehealth provider. This approach also keeps your PCP informed about your GLP-1 treatment, which is beneficial for coordinated care.

Urgent care or walk-in clinics: Some urgent care centers and walk-in clinics offer lab services. This can be a convenient option if you need labs done quickly and cannot get a prompt appointment at Quest or LabCorp. However, costs may be higher, and insurance coverage varies.

Regardless of where you get your labs, make sure the results are sent to your telehealth provider. Most platforms have a way to upload lab results through their portal. If your labs are done externally, you may need to request a copy of the results and upload them yourself.

Understanding Your Medication Options

Once your provider determines you are a good candidate for GLP-1 medication, the next question is which medication is right for you. The space of GLP-1 medications has expanded significantly, and understanding your options helps you have an informed conversation with your provider. For a deeper dive into the science behind these medications, see our complete GLP-1 medications guide.

Brand-Name vs Compounded - What Your Provider Recommends

The first major distinction in GLP-1 medications is between brand-name and compounded formulations. Understanding this distinction is important because it affects cost, availability, and the fulfillment process.

Brand-name medications are manufactured by large pharmaceutical companies (Novo Nordisk for semaglutide, Eli Lilly for tirzepatide) and are FDA-approved for specific indications. They go through rigorous clinical trials, manufacturing quality controls, and regulatory review. Brand-name GLP-1 medications include Wegovy (semaglutide for weight management), Ozempic (semaglutide for type 2 diabetes), Zepbound (tirzepatide for weight management), and Mounjaro (tirzepatide for type 2 diabetes).

Compounded medications are prepared by compounding pharmacies. These pharmacies use the same active pharmaceutical ingredients but prepare the formulations on a smaller scale. Under federal law, compounding pharmacies can prepare versions of medications that are on the FDA drug shortage list. Both semaglutide and tirzepatide have been on the shortage list at various points, which has allowed compounding pharmacies to produce these medications legally.

The key differences between brand-name and compounded GLP-1 medications come down to cost, format, and regulatory status. Brand-name medications cost roughly $1,000 to $1,300 per month at list price without insurance. Compounded versions typically cost $199 to $499 per month. Brand-name medications come in pre-filled injection pens that are convenient and easy to use. Compounded medications typically come in vials that require you to draw the dose with a syringe. Brand-name medications have FDA approval and extensive clinical trial data. Compounded medications contain the same active ingredient but are not individually FDA-approved products.

Your provider will recommend the option that makes the most sense for your situation. If you have insurance that covers brand-name GLP-1 medications, that may be the best route. If you are paying out of pocket, compounded formulations offer a more affordable alternative with the same active ingredient.

Semaglutide Options

Semaglutide is the most widely prescribed GLP-1 receptor agonist for weight management. It is available in several forms.

Wegovy is the brand name for semaglutide specifically approved for chronic weight management. The target dose is 2.4 mg injected subcutaneously once per week. In the STEP clinical trial program, participants receiving Wegovy lost an average of approximately 15 percent of their body weight over 68 weeks. Wegovy comes in pre-filled, single-use injection pens at five dose levels for the titration schedule (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg).

Ozempic is semaglutide approved for type 2 diabetes at doses up to 2 mg weekly. Some providers prescribe Ozempic off-label for weight management, though this is less common now that Wegovy is available. The doses available in Ozempic pens are 0.25 mg, 0.5 mg, 1 mg, and 2 mg.

Compounded semaglutide contains the same active ingredient as Wegovy and Ozempic. It is available in vials at various concentrations, allowing for flexible dosing. Your provider specifies the concentration and dose, and you draw the appropriate amount using a syringe. Compounded semaglutide is typically injected subcutaneously once per week, following the same dose escalation schedule as the brand-name versions.

Tirzepatide Options

Tirzepatide is a newer medication that has shown impressive results in clinical trials. Unlike semaglutide, which targets only the GLP-1 receptor, tirzepatide is a dual GIP/GLP-1 receptor agonist that targets both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors.

Zepbound is tirzepatide approved for chronic weight management. In the SURMOUNT clinical trial program, participants receiving Zepbound at the highest dose (15 mg) lost an average of approximately 21 percent of their body weight. Zepbound comes in pre-filled injection pens at multiple dose levels.

Mounjaro is tirzepatide approved for type 2 diabetes. Like the semaglutide situation, some providers prescribe Mounjaro off-label for weight management. The available doses are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.

Compounded tirzepatide availability has fluctuated depending on the FDA shortage status. When available, compounded tirzepatide follows the same active-ingredient principle as compounded semaglutide. Your provider will advise on current availability.

How Providers Choose Your Starting Medication

Your provider considers multiple factors when recommending a starting medication. These include your primary treatment goal (weight loss, blood sugar control, or both), your medical history and comorbidities, your insurance coverage and budget, current medication availability, your preferences regarding injection format (pen versus vial and syringe), and any previous experience with GLP-1 medications.

For most patients starting GLP-1 treatment for weight management, semaglutide (either Wegovy or compounded) is a common first choice because it has the longest track record, the most clinical data, and the widest availability. Tirzepatide may be recommended for patients who want the potentially greater weight loss shown in clinical trials, or for patients who have not responded adequately to semaglutide.

If you have type 2 diabetes, your provider may choose a medication and dose that offers the best combination of blood sugar control and weight loss. Both semaglutide and tirzepatide are effective for both goals, but the specific formulation and dosing may differ.

What If the First Medication Does Not Work

Not every patient has the same response to the same medication. If you have been on your GLP-1 medication for an adequate trial period (typically 12 to 16 weeks at the maintenance dose) and are not seeing the expected results, your provider has several options.

The first consideration is whether you have reached the optimal dose. Some patients respond to lower doses, while others need the maximum dose to see results. If you have not yet reached the top dose, continuing the escalation may be the first step.

The second consideration is switching medications. If you started on semaglutide and it is not producing adequate results, your provider may recommend switching to tirzepatide, which works on an additional receptor and may produce a different response. The reverse is also possible - switching from tirzepatide to semaglutide.

The third consideration is addressing lifestyle factors. Medication alone produces the best results when combined with dietary changes and increased physical activity. Your provider may review your nutrition, exercise habits, sleep quality, and stress management to identify areas where additional changes could enhance your medication’s effectiveness.

The fourth consideration is evaluating for other factors. Sometimes, an underlying condition like hypothyroidism, polycystic ovary syndrome, or medication side effects from other drugs can limit the effectiveness of GLP-1 treatment. Your provider may order additional testing to rule out these factors.

The key takeaway is that if your first medication does not produce the results you and your provider expected, there are next steps available. Treatment is not one-size-fits-all, and adjustments are a normal part of the process.

Insurance and Prior Authorization

Navigating insurance coverage for GLP-1 medications is one of the most challenging aspects of the process. The high cost of brand-name medications makes insurance coverage highly desirable, but many plans have restrictions, exclusions, or complex prior authorization requirements. Understanding the space before you start saves time and frustration. For a comprehensive breakdown of costs, see our GLP-1 cost guide and insurance coverage guide.

Checking Your Coverage Before Your Appointment

Before you even start the health assessment process, it is worth checking your insurance coverage for GLP-1 medications. This can save you significant time and help you make informed decisions about which prescribing route to pursue.

How to check your coverage:

Start by calling the member services number on the back of your insurance card. Ask specifically whether your plan covers GLP-1 medications for weight management. Be precise with the medication names - ask about Wegovy (semaglutide) and Zepbound (tirzepatide) by name. Some plans cover GLP-1 medications for diabetes but exclude them for weight management, so clarifying the intended use is important.

Ask the following questions: Does my plan cover Wegovy or Zepbound for weight management? Is prior authorization required? If so, what are the criteria for approval? What is my copay or coinsurance for this medication? Is the medication on a specialty tier? Do I need to use a specific pharmacy? Are there step therapy requirements (meaning I need to try other medications first)?

You can also check your plan’s formulary (the list of covered medications) on your insurance company’s website. Search for semaglutide, tirzepatide, Wegovy, and Zepbound. The formulary will show whether the medication is covered, what tier it is on, and whether prior authorization is required.

What you may find:

Insurance coverage for GLP-1 weight management medications varies widely. Some plans cover them generously with reasonable copays. Others exclude weight management medications entirely. Many plans fall somewhere in between, covering the medications but requiring prior authorization, step therapy, or high cost-sharing.

Employer-sponsored plans have been increasingly adding obesity coverage, but it is far from universal. Medicare Part D has historically excluded coverage of anti-obesity medications, though this has been evolving with new legislation. Medicaid coverage varies by state. Individual marketplace plans have inconsistent coverage.

The Prior Authorization Process

Prior authorization (also called preauthorization or precertification) is a process where your insurance company must approve the prescription before the pharmacy can fill it. This is standard for expensive medications and is almost always required for brand-name GLP-1 medications.

How it works:

Your provider submits a prior authorization request to your insurance company. This request includes documentation of your medical necessity for the medication: your BMI, your comorbidities, your previous weight loss attempts, and any other information the insurance company requires. The insurance company reviews the request and makes a determination.

Timeline:

Standard prior authorization reviews typically take 5 to 15 business days. Urgent requests (when medically justified) may be reviewed within 24 to 72 hours. During this time, you are waiting. You cannot fill the prescription until the prior authorization is approved.

What insurance companies look for:

Common prior authorization criteria include documented BMI meeting the FDA-approved threshold, documentation of weight-related comorbidities (for patients with BMI 27 to 29.9), evidence of previous weight loss attempts (diet, exercise, behavioral modification), a letter of medical necessity from your provider, and sometimes documentation that you have tried and failed other weight loss medications first (step therapy).

Approval vs denial:

If approved, you will receive an authorization number and can proceed to fill the prescription. Approvals are typically valid for 6 to 12 months and may need to be renewed. If denied, you have the right to appeal. We will cover the appeals process next.

What to Do If Denied

Insurance denials for GLP-1 medications are common. If your prior authorization is denied, you have several options.

Understand the reason for denial: Request a written explanation from your insurance company. Common denial reasons include not meeting BMI criteria, insufficient documentation of previous weight loss attempts, the medication not being on the plan’s formulary, and step therapy requirements not being met.

Appeal the denial: You have the right to appeal. Your provider can submit additional documentation supporting your medical necessity. This may include more detailed records of previous weight loss attempts, additional clinical documentation of comorbidities, peer-reviewed literature supporting the medical necessity of GLP-1 treatment, and a detailed letter from your provider explaining why this specific medication is necessary for your care.

Peer-to-peer review: If the initial appeal is denied, your provider can request a peer-to-peer review, which is a phone call between your provider and the insurance company’s medical director. This allows your provider to advocate directly for your treatment.

External review: If internal appeals are exhausted, most states allow you to request an independent external review of the denial. An independent medical reviewer evaluates your case and makes a binding determination.

Consider alternatives: While navigating appeals, many patients choose to start treatment through a compounded formulation, which does not require insurance authorization. You can always switch to a brand-name medication later if your appeal is successful.

When to Go the Compounding Route Instead

Many patients decide that pursuing insurance coverage is not worth the time and frustration, particularly when affordable compounded alternatives are available. Here are situations where the compounding route may make more sense:

Your insurance does not cover GLP-1 medications for weight management at all. Your insurance requires prior authorization with criteria you are unlikely to meet. The prior authorization process would delay your treatment by weeks. Your insurance copay for a brand-name medication is still very high even with coverage. You want to start treatment immediately without waiting for insurance approvals.

Compounded semaglutide and tirzepatide contain the same active ingredients as the brand-name versions and follow the same dose escalation protocols. The primary differences are the format (vials versus pre-filled pens), the cost (significantly less expensive), and the fact that compounded medications are not individually FDA-approved products (though they are legally prepared by licensed pharmacies when the brand-name versions are on the FDA shortage list).

FSA and HSA Eligibility

If you have a Flexible Spending Account (FSA) or Health Savings Account (HSA), GLP-1 medications are generally eligible expenses. This applies to both brand-name and compounded formulations, as well as the telehealth consultation fees.

Using FSA or HSA funds effectively reduces the cost of treatment by paying with pre-tax dollars. Depending on your tax bracket, this can represent a savings of 20 to 37 percent on your medication costs.

To use FSA or HSA funds, you typically need a receipt showing the medical expense and, in some cases, a letter of medical necessity from your provider. Keep all receipts from your telehealth provider and pharmacy, as your FSA or HSA administrator may request documentation.

Check with your specific FSA or HSA administrator for their documentation requirements and any spending limits that may apply.

Pharmacy Fulfillment - Brand vs Compounding

Understanding the pharmacy fulfillment process helps you know what to expect after your prescription is written. The process differs meaningfully between brand-name and compounded medications, and knowing the details ensures a smooth experience from prescription to first injection. For more on the injection process itself, see our semaglutide injection guide.

Brand-Name Pharmacy Process

When your provider prescribes a brand-name GLP-1 medication like Wegovy or Zepbound, the prescription is typically routed to a specialty pharmacy. Specialty pharmacies are different from your neighborhood retail pharmacy. They specialize in medications that require special handling, storage, or administration - including injectable biologics and temperature-sensitive drugs.

How the process works:

Your provider sends the electronic prescription to the specialty pharmacy. The pharmacy verifies the prescription and contacts your insurance company (if applicable) to process any prior authorization. Once authorization is obtained, the pharmacy fills the prescription and ships it to you.

Some telehealth platforms have preferred specialty pharmacy partners, while others allow you to choose your pharmacy. If your insurance requires you to use a specific specialty pharmacy, your provider will route the prescription accordingly.

What you receive:

Brand-name GLP-1 medications come in pre-filled, single-use injection pens. Each pen contains one dose. You will receive a box containing your month’s supply of pens (typically 4 pens for a once-weekly injection). The package also includes the manufacturer’s prescribing information, instructions for use, pen needles (or a separate needle box if not included), and the medication guide.

Pre-filled pens are designed for ease of use. You attach a needle, dial your dose (if the pen has a multi-dose dial), inject, and dispose of the pen. No measuring, no drawing up medication from a vial. This simplicity is one of the advantages of brand-name pens.

Compounding Pharmacy Process

Compounding pharmacies operate differently from retail or specialty pharmacies. They prepare medications to order, following a prescription from your provider. The two main types of compounding pharmacies are 503A and 503B.

503A compounding pharmacies prepare medications based on individual patient prescriptions. They operate under state pharmacy board oversight and federal regulations. Each preparation is made for a specific patient based on a specific prescription.

503B outsourcing facilities can prepare larger batches of medications without individual prescriptions. They are registered with and inspected by the FDA, and they follow Current Good Manufacturing Practice (cGMP) standards. 503B facilities provide an additional layer of regulatory oversight and quality assurance.

When your provider prescribes compounded semaglutide or tirzepatide, the prescription is sent to a licensed compounding pharmacy. The pharmacy prepares your medication at the specified concentration and quantity, then ships it to you.

What you receive:

Compounded GLP-1 medications typically arrive as a vial of liquid medication. Along with the vial, you will receive syringes, needles, alcohol swabs, instructions for drawing and injecting your dose, storage instructions, and the pharmacy’s contact information for questions.

Using a vial and syringe requires a few more steps than a pre-filled pen. You clean the vial top with an alcohol swab, draw the prescribed volume of medication into the syringe, inject, and properly dispose of the syringe and needle. Your provider or pharmacy will provide detailed instructions, and the process becomes routine quickly.

Shipping and Cold-Chain Requirements

Both brand-name and compounded GLP-1 medications require cold-chain shipping. This means the medication must be maintained at the proper temperature throughout the shipping process.

How cold-chain shipping works:

The pharmacy packs your medication in an insulated shipping container with gel ice packs or similar cooling elements. The packaging is designed to maintain a temperature between 36 and 46 degrees Fahrenheit (2 to 8 degrees Celsius) for the duration of shipping. Most pharmacies use overnight or 2-day shipping to minimize the time the medication spends in transit.

Seasonal considerations:

During hot summer months, cold-chain shipping is particularly important. Some pharmacies adjust their shipping methods during extreme heat, using additional insulation, more cold packs, or faster shipping options. If you live in a hot climate, consider having your medication shipped to a location where it will not sit outside in the heat for extended periods. A workplace, a neighbor who is usually home, or a pharmacy holding service can be good alternatives to a front porch in July.

What to Check When Your Package Arrives

When your medication arrives, take a few minutes to inspect it carefully before storing it.

Check the outer packaging: Is the shipping box intact? Is the insulated container inside in good condition? Are the cold packs still cold (they do not need to be frozen, but they should still be cool to the touch)?

Check the medication: Remove the vial or pen and examine it. The liquid should be clear and colorless (some compounded formulations may have a very slight tint, which is normal). Check for any particles, cloudiness, or discoloration. Verify the medication name, concentration, and expiration date on the label. Ensure the cap is intact and the vial or pen shows no signs of leakage.

Check the included supplies: If you received a compounded medication, verify that syringes, needles, and alcohol swabs are included. Check that the quantities match what your pharmacy listed on the packing slip.

What to do if something is wrong: If the cold packs are completely thawed and warm to the touch, if the medication is cloudy, discolored, or contains particles, if the packaging is damaged, or if the medication information does not match your prescription, do not use the medication. Contact the pharmacy immediately and explain the issue. Reputable pharmacies will send a replacement shipment promptly.

Storage After Delivery

Proper storage is essential for maintaining the effectiveness of your GLP-1 medication.

Refrigeration: Store your medication in the refrigerator at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius). Place it in the main body of the refrigerator, not in the door (where temperatures fluctuate more) and not near the back wall (where freezing can occur). Do not freeze GLP-1 medications. If a vial or pen has been frozen, do not use it.

In-use storage: Once you start using a vial of compounded medication, it can typically be stored in the refrigerator for the duration listed on the pharmacy’s label (often 28 to 30 days). After this period, discard any remaining medication even if it looks fine. Pre-filled pens have similar in-use storage guidelines, which are specified in the manufacturer’s instructions.

Room temperature: If needed, most GLP-1 medications can be kept at room temperature (up to 77 to 86 degrees Fahrenheit, depending on the specific product) for a limited time - typically 21 to 28 days. This can be useful for travel or situations where refrigeration is not immediately available. However, once a medication has been stored at room temperature, it should be used within the specified timeframe and not returned to the refrigerator for extended storage.

Protect from light: Keep your medication in its original packaging or container to protect it from light exposure. Direct sunlight or prolonged exposure to bright light can degrade the medication.

The FormBlends Process - How It Works

FormBlends provides a simplified telehealth platform for GLP-1 prescriptions. Here is what the process looks like from start to finish.

Creating Your Account

The first step is creating an account on the FormBlends platform. This takes about 2 minutes and requires basic information: your name, email address, date of birth, and shipping address. You will set up a secure login that gives you access to your patient portal, where you will complete your health assessment, communicate with your provider, track your treatment, and manage your prescriptions.

Your patient portal is encrypted and HIPAA-compliant. All of the health information you share is protected by the same privacy standards that apply to any healthcare provider.

Health Assessment Form

Once your account is created, you complete the health assessment form. The FormBlends assessment is comprehensive and covers all of the areas described earlier in this guide: your biometrics, medical history, medication list, weight loss history, health goals, and lifestyle factors.

The form is designed to be thorough without being overwhelming. Most patients complete it in 10 to 15 minutes. You can save your progress and come back to it if you need to gather information like medication names and doses. The platform prompts you for the level of detail your provider needs, so you know exactly what information to include.

Provider Match and Consultation

After you submit your health assessment, FormBlends matches you with a licensed provider. All FormBlends providers are board-certified physicians or nurse practitioners with experience in obesity medicine and GLP-1 prescribing. They are licensed in the state where you reside.

Your provider reviews your health assessment and initiates a consultation. Depending on your state and the specifics of your case, this may be a synchronous video consultation or an asynchronous messaging consultation. Either way, your provider takes the time to review your information, ask follow-up questions, and make a careful clinical determination.

Most patients receive their provider consultation within 24 to 48 hours of submitting their health assessment. During peak periods, it may take slightly longer, but FormBlends communicates expected timelines through the patient portal.

Prescription and Pharmacy

If your provider approves your treatment, they write a prescription and send it to a licensed pharmacy. FormBlends works with licensed compounding pharmacies and, for patients using insurance, specialty pharmacies for brand-name medications.

Your provider selects the medication, dose, and escalation schedule that best fits your medical profile. The prescription details are visible in your patient portal, so you have full transparency into your treatment plan.

Ongoing Care and Follow-Up

FormBlends provides ongoing care throughout your treatment. This includes scheduled follow-up consultations at key milestones (particularly during dose escalation), messaging access to your provider for questions or concerns between scheduled visits, monitoring of your progress including weight tracking, side effect management guidance, lab work coordination (the platform can order labs and track results), and dose adjustments as needed based on your response to treatment.

The ongoing care component is what separates a comprehensive telehealth platform from a one-and-done prescription service. Your treatment is actively managed, not just prescribed and forgotten. If you experience side effects, your provider is accessible. If you are not seeing expected results, your provider can adjust your plan. If you have questions about diet, exercise, or injection technique, you have a resource to turn to.

Pricing and What Is Included

FormBlends offers transparent pricing that includes the medical consultation, the prescription, and ongoing provider access. Specific pricing varies by medication and plan level, and current pricing is available on the semaglutide and tirzepatide product pages.

What is included in the standard FormBlends plan covers the initial health assessment and provider consultation, the GLP-1 medication (shipped monthly), ongoing follow-up care and provider access, dose adjustments and escalation management, a patient portal for tracking progress and communicating with your provider, and shipping in temperature-controlled packaging.

Lab work, if not already available from a recent test, is an additional cost. FormBlends provides lab orders that can be used at Quest Diagnostics, LabCorp, or other national lab networks. Some patients also have the option of at-home lab kits for added convenience.

Comparing Online GLP-1 Providers

The number of telehealth platforms offering GLP-1 prescriptions has grown rapidly. Choosing the right provider is an important decision that affects your care quality, cost, and overall experience. For a detailed side-by-side analysis, see our best online GLP-1 providers comparison.

What to Look For

When evaluating online GLP-1 providers, there are several critical factors to assess.

Provider licensing and credentials: Every provider who evaluates and prescribes GLP-1 medication should be a licensed, board-certified physician (MD or DO) or an advanced practice provider (NP or PA) with prescriptive authority. Verify that the providers are licensed in your state. Reputable platforms make this information readily available.

Pharmacy partnerships: Ask where the prescriptions are filled. The pharmacy should be a licensed U.S. pharmacy. If the platform uses compounding pharmacies, they should be licensed 503A or 503B facilities. Some platforms operate their own affiliated pharmacies, while others partner with independent pharmacies. Either model can work well, but transparency is key.

Follow-up care: A prescription without follow-up care is incomplete care. Your provider should be available for ongoing monitoring, dose adjustments, side effect management, and periodic re-evaluation. Ask what the follow-up schedule looks like and how you can reach your provider between scheduled visits.

Lab work coordination: Does the platform help coordinate lab work? Do they accept outside lab results? Do they offer at-home lab kits? Lab work is an important part of GLP-1 treatment, and a platform that helps you handle this process makes your life easier.

Transparent pricing: You should know exactly what you are paying for before you commit. Look for clear pricing that includes the consultation fee, the medication cost, shipping, and any other fees. Beware of platforms that advertise a low starting price but add significant fees during the process.

Red Flags to Avoid

Not all online GLP-1 providers are created equal. Here are warning signs that a provider may not be reputable:

No medical evaluation required: Any platform that offers to sell you GLP-1 medication without requiring a medical consultation is operating irresponsibly. GLP-1 medications are prescription medications that require proper medical evaluation. If a platform skips this step, avoid it.

No provider interaction: If you cannot communicate with a licensed provider at any point during the process, the platform is not providing adequate medical care. You should have access to a real provider who reviews your health information and is available for questions.

Vague pharmacy information: If the platform will not tell you which pharmacy fills the prescriptions, where the pharmacy is located, or what type of pharmacy it is, that is a red flag. Legitimate platforms are transparent about their pharmacy partners.

Unrealistic promises: Be cautious of platforms that guarantee specific weight loss results, promise prescriptions without qualification, or use high-pressure sales tactics. Responsible healthcare does not make guarantees, because individual results depend on many factors.

No follow-up care: Platforms that prescribe medication and then disappear are not providing adequate care. If there is no follow-up schedule, no provider access between visits, and no ongoing monitoring, look elsewhere.

Suspiciously low prices: While compounded medications are legitimately more affordable than brand-name versions, prices that seem too good to be true may indicate quality concerns. The active ingredients in compounded GLP-1 medications have a floor cost, and pharmacies that cut prices far below market rates may be cutting corners elsewhere.

Price Comparison Factors

When comparing prices across platforms, make sure you are comparing equivalent offerings. Consider whether the listed price includes the consultation fee (some charge separately), whether shipping is included, how much medication is included (a one-month supply versus more), whether the price is for the starting dose or the maintenance dose (higher doses cost more), whether follow-up visits are included or charged separately, and whether lab work is included or additional.

A platform that appears cheaper may actually be more expensive when you add up all the components. Conversely, a platform with a higher listed price may be more affordable when consultation, shipping, and follow-up care are bundled in.

Provider Comparison

This table provides a general comparison based on publicly available information as of March 2026. Features, pricing, and availability change frequently. Always verify current offerings directly with each platform before making a decision.

Your First Week on GLP-1 - What to Prepare

Your medication has arrived, your provider has given you the green light, and you are ready to begin treatment. The first week on a GLP-1 medication sets the tone for your entire experience. Proper preparation helps you manage side effects, build good habits, and start your treatment confidently.

Setting Up Your Injection Area

Before your first injection, set up a clean, well-lit area where you will administer the medication. This can be a bathroom counter, a kitchen table, or any flat surface with good lighting.

Gather your supplies: You will need your medication (removed from the refrigerator 15 to 30 minutes before injection to reduce discomfort - check your specific medication’s instructions), alcohol swabs, a syringe and needle (if using a compounded vial) or a pen needle (if using a pre-filled pen), a sharps disposal container (your pharmacy may provide one, or you can purchase one at any drugstore), and a clean paper towel or gauze pad.

Choose your injection site: GLP-1 medications are injected subcutaneously, which means into the fatty tissue just beneath the skin. The recommended injection sites are the abdomen (at least 2 inches away from the belly button), the front of the thigh (middle third), and the back of the upper arm (if someone else can administer the injection for you). Rotate your injection site each week to prevent tissue irritation.

First-time injection tips: If you have never given yourself an injection before, it is normal to feel nervous. The needles used for subcutaneous injections are very thin (typically 30 to 32 gauge) and short (typically 4 to 8 mm). Most patients describe the sensation as a brief pinch. You can watch the instruction video provided by your pharmacy or telehealth platform before your first injection. Take your time and follow the steps carefully. It gets easier with each injection.

Dietary Preparation

GLP-1 medications reduce appetite and slow gastric emptying, which means your eating patterns will likely change. Preparing your diet before your first injection helps you transition smoothly.

Stock your kitchen with GLP-1-friendly foods: Focus on lean proteins (chicken breast, fish, eggs, Greek yogurt, cottage cheese), vegetables (both raw and cooked), fruits in moderate portions, whole grains in moderate portions, and healthy fats (avocado, olive oil, nuts in small amounts). These foods are easy to digest, nutrient-dense, and less likely to trigger nausea.

Reduce or remove trigger foods: Fatty, greasy, and heavily processed foods are more likely to cause nausea and discomfort when you start a GLP-1 medication. Consider reducing your intake of fried foods, rich sauces, high-sugar desserts, and large portions of red meat during the first few weeks.

Plan smaller meals: Your appetite will decrease, and your stomach will empty more slowly. Eating large meals can cause significant discomfort. Plan to eat smaller, more frequent meals rather than two or three large ones. Many patients on GLP-1 medication find that 4 to 5 small meals or snacks throughout the day works better than the traditional three-meal structure.

Prioritize protein: Adequate protein intake is essential during GLP-1 treatment to help preserve lean muscle mass during weight loss. Aim for 60 to 100 grams of protein per day (your provider may give you a more specific target based on your weight and activity level). Since your overall food intake will decrease, making sure that what you do eat is protein-rich is important.

Hydration: Staying well-hydrated is important on GLP-1 medication. Nausea, which is common in the first weeks, can lead to reduced fluid intake. Aim for at least 64 ounces of water per day. Sipping water throughout the day rather than drinking large amounts at once is generally better tolerated. Some patients find that adding electrolytes to their water helps, particularly if they experience diarrhea.

First Injection Day Checklist

On the day of your first injection, follow this checklist:

Remove the medication from the refrigerator 15 to 30 minutes before your planned injection time (or as directed by your specific medication instructions). Eat a light, easy-to-digest meal a few hours before injecting. Have your injection supplies ready on a clean surface. Wash your hands thoroughly. Clean the injection site with an alcohol swab and let it dry. Administer the injection following the instructions provided by your pharmacy and provider. Apply gentle pressure to the injection site with a gauze pad if there is any slight bleeding. Dispose of the needle in your sharps container. Note the injection date, time, and site in your journal or patient portal. Store any remaining medication back in the refrigerator.

Many patients choose a specific day of the week for their injection and stick with it for consistency. Choose a day that works well with your schedule. Some patients prefer to inject on a day when they can rest if needed, such as a Friday evening, in case of first-dose side effects.

Managing First-Week Side Effects

The most common side effects when starting a GLP-1 medication are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These effects are most pronounced in the first week or two and tend to improve as your body adjusts to the medication.

Nausea management: Nausea is the most frequently reported side effect. To manage it, eat small, frequent meals instead of large ones. Avoid fatty, greasy, spicy, and overly sweet foods. Eat slowly and stop eating when you feel comfortably full, not stuffed. Stay upright for at least 30 minutes after eating. Sip ginger tea or suck on ginger candies. Stay hydrated with small, frequent sips of water. If nausea is severe, your provider may recommend an over-the-counter anti-nausea medication.

Constipation management: Drink plenty of water. Include fiber-rich foods in your diet (but increase fiber gradually, as too much fiber at once can worsen discomfort). Stay physically active, as movement helps with digestive motility. Your provider may recommend a stool softener or gentle laxative if dietary measures are not sufficient.

Diarrhea management: Stay hydrated with water and electrolyte-containing beverages. Avoid foods that can worsen diarrhea, such as high-fat foods, caffeine, and artificial sweeteners. Eat bland, easy-to-digest foods. If diarrhea is severe or persistent, contact your provider.

When to contact your provider: Most first-week side effects are mild and manageable. However, contact your provider if you are unable to keep down any food or liquids for 24 hours or more, if you have severe abdominal pain (not just mild discomfort), if you develop signs of an allergic reaction (rash, swelling, difficulty breathing), if you have severe diarrhea or vomiting that does not improve, or if you notice a lump or swelling in your neck.

Follow-Up Schedule

Your first follow-up with your provider is typically scheduled 2 to 4 weeks after starting the medication. This check-in allows your provider to assess how you are tolerating the starting dose, discuss any side effects you are experiencing, answer questions that have come up since your first injection, and plan for the first dose escalation.

After the initial check-in, follow-up appointments are typically scheduled at each dose escalation and then monthly once you reach your maintenance dose. Your provider will adjust this schedule based on your individual needs. If you are experiencing significant side effects or have concerns at any point, do not wait for your scheduled appointment. Reach out to your provider through the platform’s messaging system.

State-by-State Telehealth Regulations

Telehealth regulations vary by state, and understanding the rules that apply to your location helps you know what to expect when getting a GLP-1 prescription online. Since the expansion of telehealth during and after the COVID-19 pandemic, most states have adopted more permissive telehealth policies, but differences remain.

States with Full Telehealth Access

The majority of U.S. states allow GLP-1 prescriptions to be issued through telehealth without significant restrictions. In these states, a licensed provider can evaluate you through a video or asynchronous consultation and prescribe a GLP-1 medication without requiring an in-person visit at any point.

States that have adopted comprehensive telehealth-friendly policies generally share these characteristics: they recognize video and audio consultations as valid for establishing a provider-patient relationship, they allow asynchronous (store-and-forward) consultations for appropriate clinical scenarios, they permit out-of-state providers to practice via telehealth if they hold a license in the patient’s state, and they do not impose special restrictions on prescribing injectable medications through telehealth.

As of early 2026, most states fall into this category. However, regulations change frequently, and the specific rules can be nuanced. Your telehealth provider is responsible for ensuring compliance with your state’s laws.

States with Restrictions

Some states have specific restrictions that affect telehealth prescribing for GLP-1 medications. Common restrictions include requiring a synchronous (live video or phone) consultation for the initial visit, even if the platform offers asynchronous options. Some states require that the prescribing provider be licensed in the same state where the patient is physically located at the time of the consultation. A few states have waiting periods between the initial consultation and prescribing. Some states require additional documentation or consent forms for telehealth visits.

Important note: This table provides a general overview and should not be relied upon for legal compliance. Telehealth regulations change frequently. Your telehealth provider is responsible for ensuring they are compliant with the specific regulations of your state. If you are uncertain about your state’s rules, ask your provider directly.

How FormBlends Navigates State Laws

FormBlends operates in compliance with the telehealth regulations of each state where it provides services. The platform maintains a network of providers who are licensed in multiple states, ensuring that patients in every serviceable state are paired with an appropriately licensed provider.

When you create your account and enter your state of residence, the platform automatically applies the appropriate regulatory requirements for your location. If your state requires a video consultation, the platform will schedule one. If your state has specific consent requirements, you will be prompted to complete the necessary forms. This happens behind the scenes so you do not need to research your state’s telehealth laws yourself.

FormBlends regularly reviews and updates its compliance framework as state regulations evolve. The platform does not offer services in states where it cannot operate in full compliance with local laws.

Prescription Validity Across State Lines

A common question is whether a GLP-1 prescription from a telehealth provider in one state is valid if you travel to or live near another state. The short answer is that prescriptions are generally valid across state lines for fulfillment purposes. A prescription written by a provider licensed in your state can be filled by a pharmacy in any state.

However, there are nuances. The prescribing provider must be licensed in the state where you are physically located at the time of the consultation. If you spend significant time in multiple states (such as snowbirds or remote workers who travel frequently), make sure your provider is licensed in the state where you will be during your consultations. If you move to a new state, you may need to be reassigned to a provider licensed in your new state.

For medication shipments, your pharmacy can ship to any address in the United States, regardless of where the prescribing provider is located. This means you can receive medication at a home address, a vacation address, or any other location, as long as someone is available to receive and refrigerate the package promptly.

Frequently Asked Questions

Here are answers to the most common questions about getting a GLP-1 prescription online. For additional questions about GLP-1 medications in general, see our GLP-1 medications guide and our GLP-1 safety guide.

Can I get a GLP-1 prescription online without seeing a doctor in person?

Yes. In most U.S. states, licensed physicians and nurse practitioners can prescribe GLP-1 medications through telehealth consultations without an in-person visit. You will need to complete a health assessment, and your provider will conduct a consultation through video or secure messaging. Some states require a synchronous (live) consultation for the initial visit, but an in-person office visit is not required in most cases.

How long does it take to get a GLP-1 prescription online?

The timeline from starting your health assessment to receiving your prescription is typically 24 to 48 hours. The health assessment takes 10 to 15 minutes. The provider consultation usually happens within 24 to 48 hours. If approved, the prescription is sent to the pharmacy the same day. Medication delivery then takes an additional 3 to 7 business days. From start to first injection, most patients are looking at approximately 7 to 14 days total.

Do I need lab work before getting a GLP-1 prescription?

Most providers require or strongly recommend baseline lab work. The standard panel includes a comprehensive metabolic panel, hemoglobin A1C, lipid panel, and thyroid function tests. If you have had these labs done in the past 6 to 12 months, many providers will accept the existing results. If not, you will need to get labs drawn through an at-home kit, a lab network like Quest or LabCorp, or your primary care physician.

What BMI do I need to qualify for a GLP-1 prescription?

The FDA-approved criteria require a BMI of 30 or greater (obesity), or a BMI of 27 or greater with at least one weight-related comorbidity such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease. Your provider evaluates these criteria during the consultation and may also consider additional clinical factors.

How much does a GLP-1 prescription cost online?

Costs vary by medication type and provider. Brand-name medications (Wegovy, Zepbound) have a list price of approximately $1,000 to $1,300 per month without insurance. With insurance and a successful prior authorization, your out-of-pocket cost may be significantly lower. Compounded semaglutide and tirzepatide typically cost $199 to $499 per month, depending on the provider and dosage. Many telehealth platforms, including FormBlends, bundle the consultation fee and ongoing care into the medication price.

Is getting a GLP-1 prescription online safe?

Yes, when done through a reputable telehealth platform. Safety depends on the platform using licensed, board-certified providers, requiring a thorough medical evaluation, filling prescriptions through licensed pharmacies, requesting appropriate lab work, and providing ongoing follow-up care. These are the same standards that apply to in-person care. The delivery method (telehealth versus in-person) does not change the safety of the medication or the prescribing standards.

Can I use insurance for a telehealth GLP-1 prescription?

It depends on your specific insurance plan. Some plans cover the telehealth consultation and may cover brand-name GLP-1 medications with prior authorization. Compounded medications are generally not covered by insurance. FSA and HSA funds can typically be used for both consultations and medications. Check with your insurance provider and your telehealth platform for specific coverage details.

What is the difference between brand-name and compounded GLP-1 medications?

Brand-name medications (Wegovy, Zepbound, Ozempic, Mounjaro) are manufactured by pharmaceutical companies, FDA-approved, and sold in pre-filled injection pens. Compounded medications contain the same active ingredient (semaglutide or tirzepatide) but are prepared by licensed compounding pharmacies. They are legally available when the brand-name versions are on the FDA drug shortage list. Compounded versions typically come in vials (requiring a syringe for injection) and cost significantly less than brand-name versions.

What happens during a telehealth GLP-1 consultation?

Your provider reviews your health assessment, asks follow-up questions about your medical history and current medications, evaluates your BMI and eligibility, discusses your medication options, explains potential side effects and how to manage them, creates a treatment plan including dose escalation schedule, and answers your questions. The consultation may be conducted via live video or asynchronous secure messaging, depending on your state and the platform.

Can my primary care doctor prescribe GLP-1 medication instead?

Yes. Any licensed physician or qualified advanced practice provider can prescribe GLP-1 medications. If you have a primary care provider you trust who is experienced with these medications, that can be an excellent option. Many patients choose telehealth because of faster access, specialized expertise, and simplified processes, but the best choice depends on your individual situation and preferences.

What if I am denied a GLP-1 prescription?

If a provider determines you are not a good candidate, they should explain the reason and discuss alternatives. Common reasons include a BMI below the eligibility threshold, contraindicated medical conditions (such as medullary thyroid cancer history or MEN 2), pregnancy, or concerning drug interactions. You have the right to seek a second opinion from another provider. If you are denied by your insurance company (rather than by a provider), you can appeal the decision.

Do I need to keep seeing a provider after getting my prescription?

Yes. Ongoing follow-up is an essential part of GLP-1 treatment. Your provider monitors your progress, manages side effects, adjusts your dose during the escalation phase, orders periodic lab work, and ensures the medication continues to be safe and effective. Most platforms schedule follow-up consultations monthly or at each dose change. Skipping follow-up care increases the risk of unmanaged side effects and suboptimal treatment outcomes.

Can I get a GLP-1 prescription if I live in a rural area?

Yes. This is one of the primary advantages of telehealth. Regardless of your location, as long as you have internet access and live in a state where the provider is licensed, you can complete the entire process online and receive medication shipped to your home. Rural patients who previously had to drive hours to see a specialist can now access specialized GLP-1 care from their own home.

How do I know if an online GLP-1 provider is legitimate?

Check that the platform uses licensed, board-certified providers in your state. Verify that prescriptions are filled through licensed U.S. pharmacies. Confirm that a medical evaluation is required before any prescription is issued. Look for ongoing follow-up care as part of the service. Check for transparent pricing without hidden fees. Read patient reviews and look for the platform’s track record. Avoid any provider that sells medication without a consultation.

Will my prescription be for semaglutide or tirzepatide?

Your provider will recommend the medication best suited to your medical profile, treatment goals, and financial situation. Semaglutide has the longest track record and broadest availability. Tirzepatide has shown slightly higher average weight loss in clinical trials. Both are effective, and the choice depends on your specific circumstances. Your provider will explain their recommendation and discuss alternatives if you have a preference.

Can I switch from one GLP-1 medication to another?

Yes. Switching between GLP-1 medications is common and can be done for several reasons: intolerable side effects on the current medication, insufficient response after an adequate trial period, changes in availability, or changes in insurance coverage. Your provider will guide you through the transition, including any dose adjustments needed when switching.

Is a video call required or can I get prescribed through messages?

This depends on your state’s telehealth laws and the platform’s protocols. Some states require a synchronous consultation (live video or phone) for the initial prescription. Other states allow asynchronous consultations (secure messaging) for GLP-1 prescribing. Your telehealth platform will route you to the appropriate consultation type based on your location. Both formats involve a thorough medical evaluation by a licensed provider.

What states allow telehealth GLP-1 prescriptions?

The vast majority of U.S. states allow GLP-1 prescriptions through telehealth. Some states have specific requirements about consultation type, provider licensing, or documentation. A reputable telehealth platform only operates in states where it is fully compliant with local regulations. If you are unsure about your state, the platform will tell you during the sign-up process whether services are available in your area.

How is the medication shipped and stored?

GLP-1 medications are shipped in temperature-controlled packaging with insulated containers and cold packs. Most pharmacies use overnight or 2-day shipping to maintain the cold chain. Upon delivery, store the medication in your refrigerator at 36 to 46 degrees Fahrenheit. Do not freeze. Most formulations can be kept at room temperature for a limited period (typically 21 to 28 days) if needed, such as during travel.

Can I get a GLP-1 prescription online if I have type 2 diabetes?

Absolutely. GLP-1 medications were originally developed for type 2 diabetes and have extensive evidence supporting their use for this condition. Telehealth providers can prescribe GLP-1 medications for diabetes management through the same consultation process. Your provider will coordinate the GLP-1 medication with your existing diabetes treatment plan and may adjust your other diabetes medications (such as insulin or sulfonylureas) to prevent hypoglycemia.

What should I do to prepare before my telehealth consultation?

Before your consultation, gather your complete medical history, a list of all current medications (names, doses, and frequencies), recent lab results if available, your height and current weight, your blood pressure (if you have a home monitor), a list of questions you want to ask your provider, information about your previous weight loss attempts, and your insurance card (if planning to use insurance). Having this information ready makes the consultation more efficient and helps your provider make the best clinical decision for your care.

Managing Your GLP-1 Treatment Long-Term

Getting your prescription is just the beginning. GLP-1 treatment is typically a long-term commitment, and understanding what the months and years ahead look like helps you plan and stay on track. This section covers what to expect after your first month, during dose escalation, at your maintenance dose, and when considering whether to continue or taper your treatment.

The Dose Escalation Phase (Months 1 Through 4)

The first several months of GLP-1 treatment are defined by dose escalation. You start at the lowest dose and gradually increase every four weeks until you reach your target maintenance dose. This phase requires patience and close communication with your provider.

During dose escalation, you may experience a resurgence of gastrointestinal side effects each time your dose increases. This is normal. Your body needs time to adjust to each new dose level. The side effects are usually milder than what you experienced with the very first dose and resolve more quickly, typically within a few days to a week.

Weight loss during the escalation phase is usually modest. Most of the significant weight loss occurs after you reach your maintenance dose and sustain it for several months. Do not be discouraged if the scale does not move dramatically during the first few months. The escalation phase is about getting you safely to the therapeutic dose, not about rapid weight loss.

Your provider will check in with you at each dose increase to assess tolerability, discuss any side effects, and confirm that you are ready to move further. If side effects are too severe at a particular dose, your provider may extend the time at that dose before increasing, or may adjust the escalation schedule. This is not a setback. It is individualized care.

Keep a simple journal during this phase. Note your injection dates, any side effects, your appetite level, your energy level, and your weight. This information helps your provider make informed decisions about your dose escalation and overall treatment plan.

Reaching Your Maintenance Dose

Once you reach the target maintenance dose (2.4 mg weekly for semaglutide, or 10 to 15 mg weekly for tirzepatide, depending on your provider’s recommendation), the treatment shifts from escalation to sustaining. This is when the full therapeutic effect of the medication takes hold.

Most patients notice a significant increase in appetite suppression and weight loss after reaching the maintenance dose. Clinical trial data show that weight loss continues to accumulate for approximately 60 to 72 weeks after starting treatment, with the rate of loss gradually slowing as you approach a new equilibrium.

During the maintenance phase, your follow-up schedule typically shifts from monthly to every 2 to 3 months, depending on your stability and your provider’s preferences. You will continue to have lab work done periodically to monitor your metabolic health and ensure the medication is not causing any adverse effects on your kidneys, liver, or other organ systems.

This is also the phase where lifestyle habits become increasingly important. The appetite suppression from GLP-1 medication gives you a powerful tool, but the food choices you make, the exercise you perform, the sleep you get, and the stress you manage all contribute to your long-term outcomes. Many patients find that the reduced appetite makes it easier to adopt healthier eating patterns, since the intense cravings and hunger that previously sabotaged their efforts are significantly diminished.

Protein Intake and Exercise During Treatment

Two aspects of lifestyle deserve special emphasis during GLP-1 treatment: protein intake and resistance training. Both are critical for preserving lean muscle mass during weight loss.

When you lose weight through any method, a portion of that weight comes from lean tissue (muscle and bone) rather than fat alone. Studies suggest that 25 to 40 percent of weight lost on GLP-1 medications may be lean mass. While this is consistent with other methods of significant weight loss, it underscores the importance of protecting your muscle during treatment.

Protein is the primary dietary tool for muscle preservation. Aim for at least 1.0 to 1.2 grams of protein per kilogram of your goal body weight per day, or roughly 60 to 100 grams daily for most patients. Since your total food intake will be reduced on GLP-1 medication, you may need to be intentional about prioritizing protein at every meal. Good sources include chicken breast, fish, eggs, Greek yogurt, cottage cheese, lean beef, tofu, and protein supplements if needed to hit your daily target.

Resistance training (strength training, weight lifting) is the primary exercise tool for muscle preservation. Aim for at least 2 to 3 sessions per week, focusing on major muscle groups. You do not need to become a powerlifter. Even moderate resistance training - bodyweight exercises, resistance bands, or light dumbbells - provides meaningful protection against muscle loss. If you are new to resistance training, consider working with a personal trainer for a few sessions to learn proper form.

Cardiovascular exercise (walking, jogging, cycling, swimming) also supports your health during GLP-1 treatment by improving cardiovascular fitness, supporting mental health, and contributing to caloric expenditure. A balanced exercise routine that includes both resistance and cardiovascular training is ideal.

What to Expect at 6 Months

At the six-month mark, most patients have reached their maintenance dose and are beginning to see significant results. Clinical trial data show average weight loss of approximately 10 to 15 percent of starting body weight by six months for patients on maintenance doses of semaglutide or tirzepatide. Individual results vary considerably, and some patients see more or less weight loss at this stage.

Beyond the scale, many patients report improvements in other health markers at six months: lower blood pressure, improved blood sugar levels, better cholesterol numbers, improved energy and mobility, better sleep quality, and reduced joint pain. These improvements may be measurable through lab work and blood pressure monitoring, which your provider will coordinate.

The six-month mark is also a good time for a comprehensive review with your provider. They will assess your overall response to treatment, review updated lab work, evaluate whether any medication adjustments are needed, and discuss your long-term treatment plan.

What to Expect at 12 Months and Beyond

By the one-year mark, weight loss typically begins to plateau as your body reaches a new equilibrium. This plateau is normal and does not mean the medication has stopped working. The medication is still actively suppressing appetite, slowing gastric emptying, and providing its metabolic benefits. Your body has simply adjusted to a new, lower weight.

Clinical trials show that weight loss peaks at approximately 60 to 72 weeks and then stabilizes. Patients who continue their medication maintain their weight loss. Patients who discontinue their medication tend to regain a significant portion of the lost weight within 12 months, as the biological signals that drive appetite and weight regain return.

This is why most clinicians now view GLP-1 treatment for obesity as long-term or indefinite, similar to treating hypertension or high cholesterol with medication. The medication manages a chronic condition, and discontinuation often leads to recurrence. Your provider will discuss long-term treatment planning with you, including the option of continuing at your current dose, attempting a dose reduction to find the minimum effective dose, or transitioning to a maintenance strategy that combines lower-dose medication with sustained lifestyle changes.

Considering Discontinuation

If you and your provider decide to explore discontinuing GLP-1 medication, the process should be gradual and carefully monitored. Abruptly stopping a GLP-1 medication is not dangerous, but it can lead to a rapid return of appetite and, over time, weight regain.

A gradual taper - reducing the dose in steps over several weeks or months - may help ease the transition. During and after tapering, your provider will monitor your weight, appetite, blood sugar, and other health markers to assess how you are doing without the full medication dose.

Building strong lifestyle habits during treatment makes discontinuation more successful. Patients who have established consistent exercise routines, healthy eating patterns, adequate sleep habits, and effective stress management strategies during their time on medication are better positioned to maintain their weight loss after stopping. However, even with excellent lifestyle habits, many patients experience some weight regain after discontinuation. This is a biological reality, not a personal failure.

Your provider can help you weigh the benefits and risks of continuing versus discontinuing treatment, considering your individual health goals, risk factors, and preferences.

Special Considerations for Specific Populations

While the general process for getting a GLP-1 prescription online is the same for most patients, certain populations have specific considerations that are worth understanding.

Patients with Type 2 Diabetes

If you have type 2 diabetes, GLP-1 medications offer dual benefits: weight loss and blood sugar control. The online prescription process is the same, but your provider will pay additional attention to your current diabetes management regimen. If you take insulin or sulfonylureas, your doses may need to be reduced when starting a GLP-1 medication to prevent hypoglycemia (dangerously low blood sugar). Your provider will coordinate these adjustments and may recommend more frequent blood sugar monitoring during the initial weeks of treatment.

Your A1C level is an important baseline and monitoring tool. Expect your provider to check your A1C before starting treatment and at regular intervals (typically every 3 months) during treatment to track your blood sugar improvements.

If you are currently managing your diabetes with diet and exercise alone, or with metformin, adding a GLP-1 medication may be particularly beneficial. GLP-1 agonists address multiple aspects of type 2 diabetes - reducing blood sugar, promoting weight loss, and providing cardiovascular protection - making them a strong option for comprehensive diabetes management.

Patients Over 65

Older adults can benefit from GLP-1 treatment but may require additional monitoring. Concerns specific to older patients include a higher risk of muscle loss during weight loss (sarcopenia), potential impact on bone density, a greater need for adequate protein intake and regular resistance training, and the possibility of more pronounced side effects, particularly nausea and dehydration.

Dehydration is a particular concern in older adults. GLP-1 medications can cause nausea, vomiting, and diarrhea, all of which contribute to fluid loss. Older adults have a reduced thirst response and are already at higher risk for dehydration. Careful attention to fluid intake is essential, especially during the first weeks of treatment and during dose escalation.

Your provider will consider these factors when designing your treatment plan and may recommend a slower dose escalation schedule, more frequent follow-up, and closer attention to nutrition and exercise. Falls risk should also be assessed, as rapid weight loss can affect balance and coordination in older adults.

Patients with a History of Eating Disorders

GLP-1 medications significantly alter appetite and food intake, which requires careful consideration in patients with a history of eating disorders. If you have a history of anorexia, bulimia, binge eating disorder, or other disordered eating patterns, disclose this to your provider during the health assessment.

For patients with binge eating disorder, GLP-1 medications may actually be beneficial, as the appetite suppression can help reduce binge episodes. However, for patients with restrictive eating disorders or a history of restriction, the dramatic appetite reduction could potentially trigger or worsen restrictive patterns.

A responsible provider will evaluate whether GLP-1 medication is appropriate given your eating disorder history and may recommend concurrent support from a therapist or dietitian who specializes in eating disorders. This is not a barrier to treatment - it is an additional layer of support to ensure your treatment is safe and effective.

Patients Planning Surgery

If you have an upcoming surgery that requires general anesthesia, inform both your prescribing provider and your surgical team. Current guidelines from the American Society of Anesthesiologists recommend holding GLP-1 medications before elective surgery due to the risk of aspiration from delayed gastric emptying.

Weekly GLP-1 formulations should be held for at least one week before surgery. Some anesthesiologists recommend holding for two weeks or longer. Daily formulations should be held on the day of surgery. Your prescribing provider and anesthesiologist will coordinate the timing of your last dose before the procedure and when to resume the medication afterward.

If you are considering weight loss surgery (bariatric surgery) as an alternative or complement to GLP-1 medication, discuss this with your provider. Some patients use GLP-1 medications as a bridge to surgery, while others use surgery as a complement to medication. Your provider can help you evaluate the best approach for your situation.

Patients Who Are Pregnant or Planning Pregnancy

GLP-1 medications are contraindicated during pregnancy. Animal studies have shown potential risks to fetal development. If you are pregnant, suspect you may be pregnant, or are planning to become pregnant, do not start GLP-1 treatment. If you become pregnant while on a GLP-1 medication, discontinue the medication immediately and contact your healthcare provider.

Current guidelines recommend discontinuing semaglutide at least 2 months before planned conception due to its long half-life. For tirzepatide, the recommended washout period is at least 1 month before planned conception. If you are a woman of childbearing age starting GLP-1 treatment, your provider will discuss contraception options and pregnancy planning as part of your treatment plan.

GLP-1 medications may increase fertility by improving metabolic health and hormonal balance, particularly in women with polycystic ovary syndrome (PCOS). If you are not planning pregnancy, reliable contraception is important during treatment.

Patients Taking Mental Health Medications

Many patients considering GLP-1 treatment also take medications for depression, anxiety, bipolar disorder, or other mental health conditions. In most cases, GLP-1 medications can be used safely alongside mental health medications. However, there are a few considerations.

Some psychiatric medications, particularly certain antidepressants and antipsychotics, are associated with weight gain. Starting a GLP-1 medication while taking these drugs can still produce weight loss, but the results may be moderated. Your provider will discuss realistic expectations based on your full medication profile.

The appetite suppression and weight loss from GLP-1 medications can have positive effects on mood and self-esteem for many patients. However, rapid changes in body composition and eating patterns can also be psychologically challenging for some individuals. If you notice changes in your mood, anxiety levels, or mental health during treatment, communicate these changes to your provider promptly.

GLP-1 medications slow gastric emptying, which could theoretically affect the absorption of some oral psychiatric medications. While clinically significant interactions are uncommon, your provider may monitor your mental health medication levels more closely during the initial phase of GLP-1 treatment.

Getting Started with Your GLP-1 Prescription

The process from considering GLP-1 medication to actually starting treatment can feel overwhelming when you first begin researching your options. There is a lot of information to process: eligibility criteria, medication choices, pharmacy options, insurance navigation, side effect management, and long-term treatment planning. But when you break it down into the four core steps covered in this guide, the process is clear and manageable.

Thousands of patients complete this process every week through telehealth platforms, and the vast majority find the experience far simpler than they expected. The hardest part for many people is taking the first step and completing the health assessment. Once that is done, the process moves forward with guidance from your provider at every stage.

Getting a GLP-1 prescription online in 2026 is a straightforward process that brings specialized medical care directly to you. The four steps - health assessment, telehealth consultation, prescription, and pharmacy delivery - follow the same clinical standards as in-person care, with the added convenience of completing everything from home.

The key to a successful experience is choosing a reputable telehealth platform that prioritizes your safety and provides ongoing care. Look for licensed providers, transparent pricing, proper pharmacy partnerships, and genuine follow-up support. Avoid platforms that skip the medical evaluation or disappear after writing a prescription.

It is also worth emphasizing that you are not alone in this process. Your telehealth provider, your pharmacist, and if applicable your primary care physician all play roles in supporting your treatment. Do not hesitate to ask questions, report side effects, or request adjustments. The providers who work through telehealth platforms are accustomed to ongoing communication with their patients and welcome your engagement.

Remember that GLP-1 medication is one part of a comprehensive approach to weight management. The best outcomes come from combining medication with nutritional changes, regular physical activity, adequate sleep, and consistent follow-up with your healthcare provider. Your telehealth provider is your partner in this process, and maintaining that relationship throughout your treatment is essential.

Taking the first step toward better metabolic health is a decision that many patients describe as one of the most important they have made. The science behind GLP-1 medications is strong. The clinical evidence is extensive. And the telehealth infrastructure that exists in 2026 makes accessing this treatment more convenient and more affordable than ever before.

If you are ready to explore whether GLP-1 medication is right for you, the process starts with a simple health assessment. A licensed provider will review your information, conduct a consultation, and help you determine the best path forward for your health goals.